Strong Health answers the gray-market question in its own visible text, which almost no seller here does, and then publishes no figure on any compound page.
What Strong Health charges
Strong Health does not publish a price today.
Strong Health also sells 11 compounds this site boards without publishing a price for them: Sermorelin, CJC-1295 (board ranks no provider), Ipamorelin (board ranks no provider), Tesamorelin, BPC-157 (board ranks no provider), TB-500 (board ranks no provider), GHK-Cu, MOTS-C (board ranks no provider), PT-141, Epitalon (board ranks no provider) and NAD+.
Strong Health is not a paid partner; this link may earn a commission if that changes. Full disclosure.
By Nora Castellan, Standards EditorUpdated September 2026
It draws the research-use line itself
The sales copy carries one plain sentence: a reader will never get a gray-market or research-use-only vial from this seller. That is its own visible wording, not a summary of it.
So the seller puts itself on one side of the line, in writing, on the page taking the order. Very few sellers on this roster commit to that in a sentence.
The phrase research use only appears on both kinds of site in this market. Here it is the thing being refused rather than the disclaimer being made, so a reader gets that question settled without inference.
A comparison table that names what it is arguing against
The site publishes a table whose columns are its own clinic, med spas and IV lounges, wellness boutiques, and online research vial or gray-market sites.
Naming the alternatives is more useful than the usual vague appeal to quality. A reader can see which segment the seller thinks it competes with.
The categories are the seller's own, though, and so are the descriptions inside them. It is an argument the seller wrote about rivals it defined, not an independent comparison.
Eleven compounds, no price on any of them
Sermorelin, CJC-1295, ipamorelin, tesamorelin, BPC-157, TB-500, GHK-Cu, MOTS-c, PT-141, epitalon and NAD+ all appear on this seller's menu, each behind its own page.
Seven of those compound pages were read in one pass. Not one carries a figure, so a reader cannot compare this seller against any other on cost before making contact.
The per-compound page structure is otherwise the right one. It just stops short of the number that would make it useful for comparison.
Bloodwork is described, the company is not
The seller says baseline and monitoring bloodwork are part of how it works. Because no page attaches a figure to anything, what that bloodwork costs is not stated either.
No corporate entity is published on the pages read. A reader who wants to know which company stands behind the clinic will not find it there.
No state list is published and no dispensing pharmacy is named, so coverage and fulfillment are both questions for a first conversation.
Who it's for
Readers who want the gray-market question answered in the seller's own words first.
Buyers who want a page per compound rather than one undifferentiated menu.
Anyone comparing a clinical channel against med spas and online vial sellers.
People who want baseline and monitoring bloodwork described as part of the model.
Who should look elsewhere
Anyone who needs a figure before making contact.
Readers who want the operating company named somewhere on the site.
Buyers who treat a seller's comparison table as independent market data.
Shoppers who need a state list or a named dispensing pharmacy.
Strengths
States in its own words that it will never supply a research-use vial
Publishes a page per compound rather than a single undifferentiated peptide menu
Publishes a comparison table naming the alternatives it is arguing against
Says baseline and monitoring bloodwork are part of its model
Trade-offs
Carries no figure on any of the seven compound pages read
Publishes no corporate entity anywhere on those pages
Publishes no state list and names no dispensing pharmacy
Its comparison table describes rivals in categories it defines itself
How we verified this
Read the research-use sentence in the paragraph containing it, rather than recording the phrase as a category match.
Recorded the four columns of the seller's comparison table as the seller's own categories rather than as verified market segments.
Read seven compound pages in one pass and recorded that none of them carries a figure.
Checked the pages read for a corporate entity, a state list and a named dispensing pharmacy, and recorded that none appears.
Recorded the bloodwork claim as the seller's description of its model, noting that no page attaches a figure to it.
A provider to compare Strong Health against
Trellis Vitality
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
No. It says in its own visible text that a reader will never get a gray-market or research-use vial from it, which is the clearest form that answer takes on this roster.
What does it charge?
The site does not say. Seven compound pages were read and none carries a figure, so cost is settled after contact rather than on the page.
Is its comparison table reliable?
It is an argument, not a survey. The seller wrote both the columns and the descriptions inside them, so treat it as positioning rather than as measurement.
Is bloodwork included?
The seller describes baseline and monitoring bloodwork as part of its model. Since no page publishes a figure for anything, what that adds to a bill is not stated.
Strong Health is not a paid partner; this link may earn a commission if that changes. Full disclosure.